HIGHLIGHTS
- who: Maiko Matsushita and colleagues from the Division of Clinical Physiology and Therapeutics, Faculty of Pharmacy, Keio University, Tokyo, Japan have published the research work: Characteristics of a Novel Target Antigen against Myeloma Cells for Immunotherapy, in the Journal: (JOURNAL)
- what: The authors aimed to clarify the role of CXorf48 as a therapeutic target in multiple myeloma. In the present study, the expression of this antigen in myeloma cells was detected, and cytotoxic T lymphocyte (CTL) activity against myeloma cells was evaluated.
- how: CXorf48-specific CTL Recognized DMA-treated Myeloma Cells with Low . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.